VistaGen Therapeutics, Inc.VTGNNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank7
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P7
Near historical low
vs 3Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM-8587.85%+24.6%
2025-11386.42%-273.3%
2024-3050.09%-111.8%
202325874.89%+709.9%
2022-4242.75%-165.0%
2021-1600.83%-
20200.00%-
20190.00%-
20180.00%+100.0%
2017-781.34%-